PharmaDD Top News: Business, Technology, Strategic Briefings - Tracking leading techniques and approaches in therapeutic drug discovery and development

 

Sponsored Links:
Prescription Drug Addiction

 

 

January/February 2007

Feature Story
The Automation Equation
Power tools take center stage
for speed and efficiency.
By Pete Mitchell

Breaking the Innovation Barrier
Speakers at Pharma Forum mull
what hurts or helps.

Burrill Sees 2007 as One of Biotech’s Best 
Personalized medicine is among
areas set to expand.

At the Front Lines of Nanotechnology
Roundtable discussion on nanotechnology
and drug development.

Creating a Symphony
Epigenomics takes the genome the next step.

Briefings

How Will Pfizer Fare?
Post-Torcetrapib, analysts predict a
mix of products

Women’s Genome Health Study Launched
Public/private partnership’s study takes genotyping to grand scale.

The Push to Translational Medicine
MDS Pharma VP Claudio Carini explains what’s driving the field.

Genomic Health’s Bold Plan

Race for $1,000 Genome Heats Up
Millions in grant money drive genome sequencing.

Ultrafiltration Product Portfolios Expand
Separation tools target process development
and proteomics market.

Designer Proteins: Engineering Drug-Like Properties
Researchers boost disease-fighting protein properties.

Digital PCR Optimized
Digital arrays enable early cancer detection.

Taking Cues from Recent Blockbusters 
Angiogenesis promises to be an increasingly lucrative target.

Extending Geographic Reach

TECH BRIEF: Talking in a Foreign Language: Fluent Multilingual Clinical Trials

TECH BRIEF: Going Global Without Sacrificing Consistency and Quality in Clinical Trials

BlockBuster MAbs Fueling Big Deals
Monoclonal antibodies move industry
toward mergers and acquisitions.

Dealmakers: Major Pharma, Biotech, and Related Agreements

Editor’s Note
Drug-eluding stent debate rages.

New Products

Email this page to a friend